Congress oral presentation: ISGE 2026 AI-driven analysis of exit interviews from OASIS-1 and OASIS-2 elinzanetant clinical trials: novel insights beyond traditional endpoints

Bayer AG 2026 Open access

Read full text
Authors: Elif Inan Eroglu, Leonardo D'Ambrosi, Cecile Janssenswillen, Claudia Haberland, Nils Schoof
DOI: 10.71943/bayer.figshare.31211233
Cited by: 0

Abstract

This presentation highlights the real world impact of EZN treatment and emphasises the importance of addressing both physical and emotional aspects of the menopause.

Fields of Study & Subjects

Menopause: Health Impacts and Treatments Sentiment Analysis and Opinion Mining Cancer survivorship and care

Publication details

Journal / source
Bayer AG
Publication date
5 March 2026
Language
EN